iShares Biotechnology ETF $IBB Stake Raised by AlphaCore Capital LLC

AlphaCore Capital LLC grew its holdings in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 470.5% during the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 4,718 shares of the financial services provider’s stock after purchasing an additional 3,891 shares during the quarter. AlphaCore Capital LLC’s holdings in iShares Biotechnology ETF were worth $796,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds also recently made changes to their positions in the company. Allspring Global Investments Holdings LLC raised its holdings in shares of iShares Biotechnology ETF by 46,806.0% during the fourth quarter. Allspring Global Investments Holdings LLC now owns 46,906 shares of the financial services provider’s stock valued at $7,927,000 after buying an additional 46,806 shares during the last quarter. Aster Capital Management DIFC Ltd acquired a new position in shares of iShares Biotechnology ETF during the third quarter valued at approximately $1,907,000. Central Pacific Bank Trust Division increased its stake in shares of iShares Biotechnology ETF by 296,500.0% during the fourth quarter. Central Pacific Bank Trust Division now owns 14,830 shares of the financial services provider’s stock valued at $2,503,000 after acquiring an additional 14,825 shares during the period. Florin Court Capital LLP acquired a new position in shares of iShares Biotechnology ETF during the third quarter valued at approximately $11,116,000. Finally, Assetmark Inc. increased its stake in shares of iShares Biotechnology ETF by 150,979.6% during the fourth quarter. Assetmark Inc. now owns 74,029 shares of the financial services provider’s stock valued at $12,494,000 after acquiring an additional 73,980 shares during the period. Institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Trading Down 1.7%

NASDAQ IBB opened at $164.03 on Tuesday. iShares Biotechnology ETF has a 12 month low of $119.78 and a 12 month high of $179.64. The company’s 50 day simple moving average is $169.14 and its 200 day simple moving average is $169.70.

iShares Biotechnology ETF Cuts Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, March 20th. Shareholders of record on Tuesday, March 17th were issued a $0.1218 dividend. The ex-dividend date of this dividend was Tuesday, March 17th. This represents a $0.49 annualized dividend and a dividend yield of 0.3%.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.